期刊文献+

多西他赛联合草酸铂及亚叶酸钙,5-氟脲嘧啶治疗晚期胃癌

Docetaxel Combined with Oxaplatin and Calcium Folinate,5-Fluorouracil in the Treatment of the Advanced Gastric Carcinoma
下载PDF
导出
摘要 目的探讨多西他赛联合草酸铂及亚叶酸钙,5-氟脲嘧啶治疗晚期胃癌的疗效及毒副反应。方法多西他赛75 mg/m^2,d1、8,静脉滴注,草酸铂130 mg/m^2,d1,亚叶酸钙200 mg静脉滴注2 h后5-氟脲嘧啶500 mg/m2,持续静脉输注22 h,d1-5,21 d为1周期,所有患者均接受至少2个周期的治疗。结果全组CR 1例,PR 26例,总有效率48.2%,中位肿瘤进展时间(TTP)为6.3个月。其中初治38例,CR 0例,PR 19例,总有效率50.0%,中位TTP为6.9个月;复治18例,CR 1例,PR 7例,总有效率44.4%,中位TTP为6.1个月。主要毒副反应为骨髓抑制、恶心呕吐和脱发。结论多西他赛联合草酸铂,亚叶酸钙及5-氟脲嘧啶治疗晚期胃癌疗效肯定,特别对初治患者,毒副反应较轻,患者均能耐受,值得临床进一步扩大研究。 Objective To study the short-term efficacy ad toxicities of docetaxel combined with oxaliplatin and 5-fluorouracil in the treatment of advanced gastric carcinoma. Methods 56 patients with advanced gastric carcinoma were treated with doeetaxel(75 mg/m^2 ,d1,8 ) , oxaliplatin( 130 mg/m^2 ,d1 ) and 5-fluorouraeil(500 mg/m^2 , d 1-5 ) , The chemotherapy was repeated every 21 days . All the patients were cured over two cycles treatments. Results There were l CR and 26 PR in all the cases ,the overall response rate was 48.2% ,the median TTP is 6.3 months. Among the primary treatment 38 patients,there was 0 CR and 19 PR, the overall response rate was 50.0% , the median TTP was 6.9 months. Among the retreated 18 patients,there was 1 CR and 7 PR, the overall response rate was 44.4% , the median TTP was 6.1 months. Major toxicities were bone marrow depression, nausea, vomitting and alopecia. Conclusion Docetaxel combined with oxaliplatin and 5-fluorouraeil in the treatment of advanced gastric carcinoma is effective. Especially for the primary treatment patients,the toxicities can be tolerant. It is worth expanding in the clinical work.
出处 《肿瘤基础与临床》 2009年第5期403-404,共2页 journal of basic and clinical oncology
关键词 晚期胃癌 多西他赛 草酸铂 亚叶酸钙 5-氟脲嘧啶 advanced gastric carcinoma docetaxel oxaliplatin calcium folinate 5-fluorouraeil
  • 相关文献

参考文献6

  • 1金懋林.胃癌内科化学治疗的新进展[J].医学临床研究,2003,20(10):735-738. 被引量:68
  • 2Sasaki T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence [ J]. Gan To Kagaku Ryoho, 2000, 27 (2) : 166 - 176.
  • 3Sasaki T, Maeda Y, Kobayashi T, et al. New combination therapies for gastrointestinal cancer [ J ]. Gan To Kagaku Ryoho, 2000, 27 (3) :348-355.
  • 4Ajani JA. Docetaxel for gastric and esophageal carcinomas [ J]. Oncology (Williston Park), 2002, 16 (6 Suppl 16) :89 - 96.
  • 5秦叔逵,龚新雷.晚期胃癌化疗的现状和新进展[J].临床肿瘤学杂志,2006,11(9):641-652. 被引量:268
  • 6Ajani JA, Fodor MB, Tjulandin SA, et al. Phase Ⅱ multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma [ J ]. J Clin Oncol, 2005,23 (24) : 5660 -5667.

二级参考文献27

  • 1钱军,秦叔逵,梅静峰,陈映霞,邵志坚,何泽明.奥沙利铂联合卡培他滨二线治疗晚期胃癌的临床观察[J].中华肿瘤杂志,2004,26(12):746-748. 被引量:60
  • 2Sasaki T, Maeda Y, Kobayashi T, et al. Standard chemotherapy for gastrointestinal malignancies based on evidence[J]. Jap J Cancer Chemother , 2000,27(20):166-176.
  • 3Findlay M, Cunningham D, Norman A, et al . A phase Ⅱ study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF)[J]. Ann Oncol ,1994,5:609-616.
  • 4Cocconi G. Fluorouracil, doxorubicin,and mitomycin combination versus PELF chemotherapy in advanced gastric cancer:a prospective randomized trial of the Italian Oncology Group for Clinical Research[J]. J Clin Oncol ,1994,21(12) :2687.
  • 5Kim YH, Shin SW, Kim BS, et al . Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J]. Cancer , 1999,85:295-301.
  • 6Ajani J. Clinical update on an international phase Ⅱ/Ⅲ docetaxel trial(TAX 325)[J]. Proc Update Meeting on GIC ,2002.
  • 7Kim T, Ahn J,Lee J,et al . A phase Ⅱ trial of capecitabine( X )and cisplantin(P)in previously untreated advanced gastric cancer(AGC)[J]. Proc Am Soc Clin Oncol , 2001,20 : 166.
  • 8金懋林.抗癌新药治疗胃癌进展[A]..抗癌药物与肿瘤化学治疗进展[C].北京:科学出版社,2001.55—64.
  • 9Moiseyenko VM,Ajani JA,Tjulandin SA,et al.Final results of a randomized controlled phase Ⅲ trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F)to CF in patients (pts) with metastatic gastric adenocarcinoma (MGC)[ J ].J Clin Onc,Proc Am Soc Clin Oncol,2005,23:Abstract 4002.
  • 10Al-Batran S,Hartmann J,Probst S,et al.A randomized phase Ⅲ trial in patients with advanced adenocarcinoma of the stomach receiving first-line chemotherapy with fluorouracil,leucovorin and oxaliplatin (FLO) versus fluorouracil,leucovorin and cisplatin (FLP)[J].J Clin Onc,Proc Am Soc Clin Oncol,2006,24:Abstract 4016.

共引文献327

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部